 | Up a level |
Lee, S. -h. and Menis, J. and Kim, T. M. and Kim, H. R. and Zhou, C. and Kurniawati, S. A. and Prabhash, K. and Hayashi, H. and Lee, D. d. -w. and Imasa, M. S. and Teh, Y. L. and Yang, J. c. -h. and Reungwetwattana, T. and Sriuranpong, V. and Wu, C. -e. and Ang, Y. and Sabando, M. and Thiagarajan, M. and Mizugaki, H. and Noronha, V. and Yulianti, M. and Zhang, L. and Smyth, E. and Yoshino, T. and Park, J. O. and Pentheroudakis, G. and Park, S. and Peters, S. and Ahn, J. B. and Popat, S. (2024) Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancer. ESMO Open, 9 (12). p. 103996. ISSN 2059-7029, DOI https://doi.org/10.1016/j.esmoop.2024.103996.
Passaro, A. and Wang, J. and Wang, Y. and Lee, S. -H. and Melosky, B. and Shih, J. -Y. and Wang, J. and Azuma, K. and Juan-Vidal, O. and Cobo, M. and Felip, E. and Girard, N. and Cortot, A. B. and Califano, R. and Cappuzzo, F. and Owen, S. and Popat, S. and Tan, J. -l. and Salinas, J. and Tomasini, P. and Gentzler, R. D. and William, W. N. and Reckamp, K. L. and Takahashi, T. and Ganguly, S. and Kowalski, D. M. and Bearz, A. and MacKean, M. and Barala, P. and Bourla, A. B. and Girvin, A. and Greger, J. and Millington, D. and Withelder, M. and Xie, J. and Sun, T. and Shah, S. and Diorio, B. and Knoblauch, R. E. and Bauml, J. M. and Campelo, R. G. and Cho, B. C. and Investigators, MARIPOSA-2 (2024) Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study. Annals of Oncology, 35 (1). ISSN 0923-7534, DOI https://doi.org/10.1016/j.annonc.2023.10.117.
